Ignyta Appoints Dr. Christian V. Kuhlen As General Counsel

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Dr. Christian V. Kuhlen has been appointed to serve as its General Counsel and Secretary, replacing Matt Onaitis. Since 2007, Dr. Kuhlen served as General Counsel, Vice President and Secretary of Genoptix, Inc., where he led the legal and corporate governance functions from its initial public offering in 2007, through its successful acquisition by Novartis in 2011. Following the completion of Genoptix’s acquisition, Dr. Kuhlen continued to serve the company in these capacities, as well as leading its internal public policy function.